These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2886875)

  • 1. Effects of psychotropic drugs on neurotransmitters in man.
    Potter WZ; Rudorfer MV; Pickar D; Linnoila M
    Life Sci; 1987 Aug; 41(7):817-20. PubMed ID: 2886875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotic drugs and drugs inducing psychoses].
    Deniker P
    Acta Psychiatr Belg; 1983; 83(3):239-54. PubMed ID: 6138922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Jun; 255(3):190-201. PubMed ID: 15995903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter interactions as a target of drug action.
    Potter WZ; Hsiao JK; Agren H
    Psychopharmacol Ser; 1989; 7():40-51. PubMed ID: 2574455
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsychotic drugs, neurotransmitters, and schizophrenia.
    Carlsson A
    Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin in antipsychotic drugs action.
    Amato D
    Behav Brain Res; 2015 Jan; 277():125-35. PubMed ID: 25078293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical implications of present knowledge respecting neuropharmacologic control of antipituitary hormones].
    Martin-Du Pan R; Vallotton MB
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1784-1814. PubMed ID: 6116277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications.
    Carlsson A; Hansson LO; Waters N; Carlsson ML
    Life Sci; 1997; 61(2):75-94. PubMed ID: 9217267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronopharmacology of psychotropic drugs: circadian rhythms in drug effects and its implications to rhythms in the brain.
    Nagayama H
    Pharmacol Ther; 1993; 59(1):31-54. PubMed ID: 7903122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Metabolite Concentrations in the Left Dorsolateral Prefrontal Cortex, the Left Frontal White Matter, and the Left Hippocampus in Patients in Stable Schizophrenia Treated with Antipsychotics with or without Antidepressants. ¹H-NMR Spectroscopy Study.
    Strzelecki D; Grzelak P; Podgórski M; Kałużyńska O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A
    Int J Mol Sci; 2015 Oct; 16(10):24387-402. PubMed ID: 26501256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of neurotransmitters to the symptoms of major depressive disorder.
    Nutt DJ
    J Clin Psychiatry; 2008; 69 Suppl E1():4-7. PubMed ID: 18494537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology of schizophrenia: neurochemical aspects].
    de las Cuevas Castresana C; González de Rivera JL
    Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy with neuroleptics and antidepressive agents: a fundamental and critical discussion from a biological viewpoint].
    Langer G
    Wien Klin Wochenschr; 1983 Jul; 95(14):474-8. PubMed ID: 6138904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.